Grant of Interim Extension of the Term of U.S. Patent No. 7,534,790; Vernakalant Hydrochloride, 1712-1713 [2019-01049]

Download as PDF 1712 Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices The meeting will be held via webinar with a telephone-only connection option. Council address: Mid-Atlantic Fishery Management Council, 800 N. State Street, Suite 201, Dover, DE 19901; telephone: (302) 674–2331 or on their website at www.mafmc.org. FOR FURTHER INFORMATION CONTACT: Christopher M. Moore, Ph.D., Executive Director, Mid-Atlantic Fishery Management Council, telephone: (302) 526–5255. SUPPLEMENTARY INFORMATION: The purpose of the meeting is to create fishery performance reports for blueline and golden tilefish by the Council’s Tilefish Advisory Panel. The intent of these reports is to facilitate a venue for structured input from the Advisory Panel members for the Tilefish specifications processes, including recommendations to the Council and its Scientific and Statistical Committee. ADDRESSES: Dated: January 31, 2019. Jennifer M. Wallace, Acting Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2019–01050 Filed 2–4–19; 8:45 am] BILLING CODE 3510–22–P the webinar, please (1) dial this TOLL number 1–562–247–8321 (not a toll-free number), (2) enter the attendee phone audio access code 835–605–745, and (3) enter the provided audio PIN after joining the webinar. You must enter this PIN for audio access. NOTE: We have disabled Mic/Speakers as an option and require all participants to use a telephone or cell phone to participate. Technical Information and system requirements: PC-based attendees are required to use Windows® 7, Vista, or XP; Mac®-based attendees are required to use Mac OS® X 10.5 or newer; Mobile attendees are required to use iPhone®, iPad®, AndroidTM phone or Android tablet (See the https:// www.gotomeeting.com/webinar/ipadiphone-android-webinar-apps.) You may send an email to Mr. Kris Kleinschmidt at Kris.Kleinschmidt@ noaa.gov or contact him at 503–820– 2280, extension 411 for technical assistance. A public listening station will also be available at the Pacific Council office. Council address: Pacific Fishery Management Council, 7700 NE Ambassador Place, Suite 101, Portland, OR 97220. Dr. Kit Dahl, Pacific Council; telephone: (503) 820–2422. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration RIN 0648–XG747 Pacific Fishery Management Council; Public Meeting National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce. ACTION: Notice of public meeting (webinar). AGENCY: The Pacific Fishery Management Council’s (Pacific Council) Highly Migratory Species Management Team (HMSMT) will hold a webinar, which is open to the public. DATES: The webinar meeting will be held on Friday, February 22, 2019, from 1:30 p.m. until 4:30 p.m. The webinar time is an estimate; the meeting will adjourn when business for the day is completed. ADDRESSES: The meeting will be held via webinar. A public listening station is available at the Pacific Council office (address below). To attend the webinar (1) join the meeting by visiting this link https://www.gotomeeting.com/webinar, (2) enter the Webinar ID: 544–381–883, and (3) enter your name and email address (required). After logging in to SUMMARY: VerDate Sep<11>2014 17:22 Feb 04, 2019 Jkt 247001 The primary purpose of this HMSMT webinar is to prepare for the March 2019 Council meeting. The HMS topics on the Council’s March agenda are: (1) National Marine Fisheries Report, (2) International Management Recommendations, and (3) Drift Gillnet Fishery Performance Metrics Review. The HMSMT may also discuss other items related to HMS management and administrative Pacific Council agenda items. A detailed agenda for the webinar will be available on the Pacific Council’s website prior to the meeting. The HMSMT may also address other assignments relating to HMS management. No management actions will be decided by the HMSMT. Although non-emergency issues not contained in the meeting agenda may be discussed, those issues may not be the subject of formal action during this meeting. Action will be restricted to those issues specifically listed in this document and any issues arising after publication of this document that require emergency action under section 305(c) of the Magnuson-Stevens Fishery Conservation and Management Act, provided the public has been notified of the intent to take final action to address the emergency. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 Special Accommodations This meeting is physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aids should be directed to Mr. Kris Kleinschmidt at (503) 820–2411 at least 10 business days prior to the meeting date. Dated: January 31, 2019. Jennifer M. Wallace, Acting Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2019–01052 Filed 2–4–19; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF COMMERCE Patent and Trademark Office [Docket No.: PTO–P–2019–0002] Grant of Interim Extension of the Term of U.S. Patent No. 7,534,790; Vernakalant Hydrochloride United States Patent and Trademark Office, Commerce. ACTION: Notice of interim patent term extension. AGENCY: The United States Patent and Trademark Office has issued an order granting interim extension under for a one-year interim extension of the term of U.S. Patent No. 7,534,790. FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571) 272– 7755; by mail marked to her attention and addressed to the Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, Alexandria, VA 22313– 1450; by fax marked to her attention at (571) 273–7755; or by email to Mary.Till@uspto.gov. SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code, generally provides that the term of a patent may be extended for a period of up to five years if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review, and that the patent may be extended for interim periods of up to one year if the regulatory review is anticipated to extend beyond the expiration date of the patent. On December 28, 2018, Correvio International Sa`rl, the patent owner of record, timely filed an application under 35 U.S.C. 156(d)(5) for an interim extension of the term of U.S. Patent No. 7,534,790. The patent claims the human drug product, vernakalant hydrochloride. The application for patent term extension indicates that New Drug Application (NDA) 22–034 was submitted to the Food and Drug SUMMARY: E:\FR\FM\05FEN1.SGM 05FEN1 Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices Administration (FDA) on December 19, 2006. Review of the patent term extension application indicates that, except for permission to market or use the product commercially, the subject patent would be eligible for an extension of the patent term under 35 U.S.C. 156, and that the patent should be extended for one year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory review period will continue beyond the original expiration date of the patent, March 31, 2019, interim extension of the patent term under 35 U.S.C. 156(d)(5) is appropriate. An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. Patent No. 7,534,790 is granted for a period of one year from the original expiration date of the patent. Dated: January 29, 2019. Robert Bahr, Deputy Commissioner for Patent Examination Policy, United States Patent and Trademark Office. [FR Doc. 2019–01049 Filed 2–4–19; 8:45 am] DEPARTMENT OF DEFENSE Department of the Army Intent To Grant an Exclusive License for U.S. Government-Owned Invention Department of the Army, DoD. Notice. AGENCY: In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, Attn: Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: Dr. Paul Michaels, Office of Research & Technology Applications, (301) 619– 4145. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619– 7808, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to United States Patent 7,867,983, filed March 25, 2008, entitled ‘‘Methods to Protect Skeletal Muscle Against Injury,’’ to the University of Connecticut, having its principal place of business at 400 Farmington Avenue, Farmington, CT 06032. SUMMARY: VerDate Sep<11>2014 17:22 Feb 04, 2019 Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2019–01055 Filed 2–4–19; 8:45 am] BILLING CODE 5001–03–P DEPARTMENT OF DEFENSE Office of the Secretary Vietnam War Commemoration Advisory Committee; Notice of Federal Advisory Committee Meeting; Amendment Chief Management Officer, Vietnam War Commemoration Advisory Committee, Department of Defense. ACTION: Notice of federal advisory committee meeting. AGENCY: On Wednesday, December 26, 2018, the Department of Defense (DoD) published a notice to announce that the following Federal Advisory Committee meeting of the Vietnam War Commemoration Advisory Committee will be held on February 8, 2019. Subsequent to the publication of this notice, the start time for this meeting has changed. The public is asked to arrive no later than 10:15 a.m. The meeting will begin promptly at 10:30 a.m. All other information in the December 26, 2018 notice remains the same. DATES: Open to the public Friday, February 8, 2019 from 10:15 a.m. to 4:00 p.m. ADDRESSES: The address of the open meeting is 241 18th Street South, Room 101, Arlington VA 22202. FOR FURTHER INFORMATION CONTACT: Mrs. Marcia L. Moore, 703–571–2005 (Voice), 703–692–4691 (Facsimile), marcia.l.moore12.civ@mail.mil (Email) or Mr. Mark Franklin, 703–697–4849 (Voice), mark.r.franklin.civ@mail.mil (Email). Mailing address is DOD Vietnam War Commemoration Program Office, 241 18th Street South, Suite 101, Arlington, VA 22202. Website: http:// www.vietnamwar50th.com. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of the Department of Defense (DoD) and the Designated Federal Officer, the Vietnam War Commemoration Advisory Committee was unable to provide public SUMMARY: BILLING CODE 3510–16–P ACTION: Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). Jkt 247001 PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 1713 notification required by 41 CFR 102– 3.150(a) concerning its need to amend the previously published notice about the February 8, 2019 meeting of the Vietnam War Commemoration Advisory Committee. Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 CFR 102–3.150(b), waives the 15calendar day notification requirement. This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. Purpose of the Meeting: The Department of Defense is publishing this notice to announce the following Federal advisory committee meeting of the Vietnam War Commemoration Advisory Committee. This meeting is open to the public. The Committee is asked to provide advice on the concept and design of the types of commemoration events the Vietnam War Commemoration Office (VWC) should consider supporting or coordinating during the close-out phase from 2023 through 2025. The objective for this meeting is to finalize the Advisory Committee’s recommendations. Agenda: The Committee will convene from 10:15 a.m. to 4:00 p.m. on February 8, 2019 to finalize the Committee’s recommendations on the concept and types of commemoration events the Vietnam War Commemoration Office (VWC) should consider supporting or coordinating during the close-out phase from 2023 through 2025. Meeting Accessibility: Special Accommodations: Individuals requiring special accommodations to access the public meeting should contact Mrs. Marcia Moore or Mr. Franklin at the number listed in the FOR FURTHER INFORMATION CONTACT section by February 1, 2019 so that appropriate arrangements can be made. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140, and section 10(a)(3) of the Federal Advisory Committee Act of 1972, the public or interested organizations may submit written comments to the Committee about its mission and topics pertaining to this public meeting. Written comments should be received by the DFO by February 1, 2019. Written comments should be submitted via email to the address for the DFO given in the FOR FURTHER INFORMATION CONTACT section in either Adobe Acrobat or Microsoft Word format. Please note that since the Committee E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 84, Number 24 (Tuesday, February 5, 2019)]
[Notices]
[Pages 1712-1713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01049]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Patent and Trademark Office

[Docket No.: PTO-P-2019-0002]


Grant of Interim Extension of the Term of U.S. Patent No. 
7,534,790; Vernakalant Hydrochloride

AGENCY: United States Patent and Trademark Office, Commerce.

ACTION: Notice of interim patent term extension.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office has issued an 
order granting interim extension under for a one-year interim extension 
of the term of U.S. Patent No. 7,534,790.

FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571) 
272-7755; by mail marked to her attention and addressed to the 
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, 
Alexandria, VA 22313-1450; by fax marked to her attention at (571) 273-
7755; or by email to Mary.Till@uspto.gov.

SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code, 
generally provides that the term of a patent may be extended for a 
period of up to five years if the patent claims a product, or a method 
of making or using a product, that has been subject to certain defined 
regulatory review, and that the patent may be extended for interim 
periods of up to one year if the regulatory review is anticipated to 
extend beyond the expiration date of the patent.
    On December 28, 2018, Correvio International S[agrave]rl, the 
patent owner of record, timely filed an application under 35 U.S.C. 
156(d)(5) for an interim extension of the term of U.S. Patent No. 
7,534,790. The patent claims the human drug product, vernakalant 
hydrochloride. The application for patent term extension indicates that 
New Drug Application (NDA) 22-034 was submitted to the Food and Drug

[[Page 1713]]

Administration (FDA) on December 19, 2006.
    Review of the patent term extension application indicates that, 
except for permission to market or use the product commercially, the 
subject patent would be eligible for an extension of the patent term 
under 35 U.S.C. 156, and that the patent should be extended for one 
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory 
review period will continue beyond the original expiration date of the 
patent, March 31, 2019, interim extension of the patent term under 35 
U.S.C. 156(d)(5) is appropriate.
    An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. 
Patent No. 7,534,790 is granted for a period of one year from the 
original expiration date of the patent.

    Dated: January 29, 2019.
Robert Bahr,
Deputy Commissioner for Patent Examination Policy, United States Patent 
and Trademark Office.
[FR Doc. 2019-01049 Filed 2-4-19; 8:45 am]
 BILLING CODE 3510-16-P